CooperCompanies, US21664P1039

CooperCompanies stock falls as Q3 2026 miss and guidance cut weigh on outlook

Published on 09/14/2026 at 23:19 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

CooperCompanies stock has come under pressure after Q3 2026 revenue of USD 1.07 billion missed expectations on September 9, 2026, and earnings guidance was cut. The Cooper Companies stock closed near USD 54 on Nasdaq on September 11, 2026, well below its 52-week high after a sharp post-earnings sell-off.

Reinraum-Produktionsanlage für medizinische Geräte mit Technikern an Kontaktlinsen-Fertigungslinien
CooperCompanies Reinraum-Produktion US21664P1039 zeigt automatisierte Kontaktlinsen-Fertigungslinien mit optischer Qualitätsprüfung im sterilen Reinraumbereich, Illustration mit AI erstellt.

CooperCompanies stock has come under renewed pressure after The Cooper Companies Inc. (ISIN US21664P1039, Nasdaq: COO) reported fiscal Q3 2026 results that missed revenue expectations and cut its full-year guidance, triggering a double-digit share-price slide around September 9, 2026.

Q3 2026 results and guidance cut hit sentiment

According to Yahoo Finance on September 14, 2026, The Cooper Companies posted fiscal Q3 2026 revenue of USD 1.07 billion, below Wall Street estimates of roughly USD 1.10 billion, while adjusted EPS of USD 1.15 per share came in modestly above consensus.

In the same report, management lowered its fiscal 2026 adjusted earnings outlook to a range of USD 4.51 to USD 4.55 per share, down from a prior forecast of USD 4.58 to USD 4.66 per share, and reduced revenue guidance to USD 4.23 to USD 4.25 billion compared with the earlier range of USD 4.29 to USD 4.32 billion, underscoring weaker-than-expected demand in parts of the business.Yahoo Finance

CooperVision destocking drags revenue and growth outlook

As Yahoo Finance reports, the revised guidance reflects softer contact lens demand in the CooperVision segment, where the company now expects organic growth of only about 1 to 2 percent for fiscal 2026 compared with more robust expectations at the start of the year.

The company also signaled that fourth-quarter CooperVision organic growth is likely to range between minus 2 percent and zero percent, highlighting that ongoing US channel inventory reductions and weaker near-term demand are weighing on top-line momentum even as earnings per share in Q3 2026 improved year-on-year from USD 0.49 to USD 1.15.Yahoo Finance

Analyst reactions, investigation headlines and stock performance

Following the earnings miss and guidance cut, several analyst summaries pointed to a more cautious stance on CooperCompanies stock. According to MarketBeat on September 14, 2026, the consensus rating currently stands at Hold with an average target price of USD 71.47, while Piper Sandler recently cut its rating from Overweight to Neutral and reduced its target from USD 86.00 to USD 59.00.

The same MarketBeat overview notes that management set Q4 2026 EPS guidance at USD 1.05 to USD 1.09, below prior expectations, and fiscal 2026 EPS guidance at USD 4.51 to USD 4.55, which helped drive analyst downgrades even though the company also authorized a sizeable USD 3.00 billion share-repurchase program covering up to roughly 22.7 percent of outstanding shares.MarketBeat

Regulatory risk also entered the picture. A report from GuruFocus on September 14, 2026, describes how SueWallSt has notified investors of a shareholder investigation into Cooper Companies after quarterly revenue of about USD 1.07 billion came in roughly USD 30 million below analyst consensus and the stock declined on the shortfall.

The market reaction has been pronounced. Per recent quote data cited by Investing.com, CooperCompanies stock was trading around USD 54.29 on Nasdaq with intraday gains of about 0.7 percent and a day range between USD 54.12 and USD 54.99, while the 52-week price span stood between approximately USD 51.01 and USD 89.83 as of mid-September 2026, leaving the shares near the lower end of their one-year range.Investing.com

Stock valuation and recent performance

For investors, the combination of weaker revenue, lowered guidance and heightened scrutiny has shifted attention to valuation and recent performance metrics. As Zacks highlighted on September 14, 2026, CooperCompanies stock carries a Zacks Rank of 5, indicating a Strong Sell rating in that framework, with the shares down 29.2 percent over the past month compared with a 0.8 percent decline in the Zacks S and P 500 composite index.

Over the past three months, the same Zacks analysis shows CooperCompanies stock falling 18.2 percent while the S and P 500 rose 3.9 percent, underscoring how company-specific issues tied to CooperVision destocking and the guidance cut have driven underperformance relative to both the broader US equity benchmark and the medical sector, which declined about 2 percent in the period.Zacks

Closing snapshot: CooperCompanies stock price and range

CooperCompanies stock recently closed at about USD 53.91 on the Nasdaq on September 11, 2026, positioning the shares in the mid-USD-50s and leaving them significantly below their 52-week high near USD 89.83 while only a few dollars above the 52-week low around USD 51.01, a sign that the market is still digesting the Q3 2026 revenue miss and the cut to fiscal 2026 guidance.

CooperCompanies stock key data

  • Company: The Cooper Companies Inc.
  • ISIN: US21664P1039
  • Ticker: COO
  • Trading venue: Nasdaq
  • Price (as of September 11, 2026): 53.91 USD
  • Market capitalization: 1,700,000,000 USD (as of September 10, 2026)
  • Sector / Industry: Health Care / Medical Devices
  • Index membership: S and P 500

More news and analyses on CooperCompanies stock

Disclaimer...

en | US21664P1039 | COOPERCOMPANIES | boerse | 70101641 | bgmi